Product Description
2.5mg Bortezomib Injection IP is a liquid medication originating from India. It is made from 100% yeast and has a shelf life of 6-12 months when stored in a cool place. This injection is primarily used for the treatment of multiple myeloma and mantle cell lymphoma. It works by blocking certain proteins in cancer cells, which in turn slows down the growth and spread of cancer cells. The dosage of this injection is determined by a healthcare professional and should not be self-administered. This medication is only available with a prescription and should be used only as directed.
FAQs of 2.5mg Bortezomib Injection IP:
Q: What is the recommended dosage for 2.5mg Bortezomib Injection IP?
A: The recommended dosage of this injection is determined by a healthcare professional and is based on the patients medical condition, response to treatment, and other medications they may be taking.
Q: How is 2.5mg Bortezomib Injection IP administered?
A: This injection is administered by a healthcare professional through a vein (intravenous infusion) and should not be self-administered.
Q: What are the side effects of 2.5mg Bortezomib Injection IP?
A: The common side effects of this injection may include nausea, diarrhea, constipation, headache, fatigue, and fever. However, if any serious side effects occur, seek medical attention immediately.
Q: Can 2.5mg Bortezomib Injection IP be used during pregnancy or breastfeeding?
A: It is not recommended to use this injection during pregnancy or breastfeeding. Consult with a healthcare professional before using this medication.
Q: How should 2.5mg Bortezomib Injection IP be stored?
A: This injection should be stored in a cool place and kept out of reach of children. Do not freeze or shake the medication and discard any unused medication appropriately.